Skip to main navigation Skip to search Skip to main content

PFI-TT: Development of A Rapid and Reliable Point-of-Care Screening for Infectious Diseases (COVID-19)

Project: Research

Abstract & Details

Description

Award ID: 2141141

The broader impact/commercial potential of this Partnerships for Innovation - Technology Translation (PFI-TT) project is to improve public health outcomes in combating pandemic/epidemic diseases, such as COVID-19. An urgent need exists for a rapid, cost-effective, facile and reliable assays for mass screening to control and prevent the spread of emerging pandemic diseases. The proposed project will demonstrate a mass screening method to rapidly detect viruses, which can be used to identify early infected individuals for quarantine. The proposed product can be potentially used in many settings such as test centers, clinics, school health clinics and airport controls. The project will also: offer research and internship opportunities for students from diverse backgrounds and underrepresented groups, as well as local K-12 teachers and students; entrepreneurship training for participating students; and develop new industrial-academic partnerships. This work will enable rapid and reliable point-of-care detection with benefits of affordability, simplicity and rapidity, which will reduce user onboarding time and costs. The proposed project will address the current challenge of a rapid, affordable, facile and reliable detection in molecular sensing and diagnosis. The proposed project will develop a novel mechanism of engineering smart molecular devices by integrating molecular computation with specific target recognition and signal amplification on the nanoscale. The specific goals include the development of a solution assay to rapidly detect viral RNA, and a user-friendly system for integration with a lateral-flow device. The proposed research will employ a multidisciplinary approach that combines computational design, molecular assembly and circuits, and biochemical assays. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

NSF Program Director: Mara E. Schindelholz
StatusClosed
Effective start/end date07/01/2206/30/25

Funding

  • Other Programs (Technology): $249,999.00

Active Fiscal Year

  • FY2024
  • FY2023
  • FY2022
  • FY2025

Start Fiscal Year

  • FY2022

TIP Programs

  • Other Programs (Technology)

Key Technology Areas

  • Biotechnology
  • (confidence score: 100%)
  • Disaster Prevention and Mitigation
  • (confidence score: 100%)

Technology Foci

  • Synthetic Biology
  • (confidence score: 100%)
  • Medical Technology
  • (confidence score: 99%)
  • Pandemic prevention and response
  • (confidence score: 100%)

Congressional District at Award

  • District n. 01 of New Jersey

Current Congressional District

  • District n. 01 of New Jersey

United States

  • New Jersey

Core Based Statistical Area (CBSA)

  • Philadelphia-Camden-Wilmington, PA-NJ-DE-MD

County

  • County: Camden, NJ

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint. Learn more about Elsevier's Fingerprint Engine here: https://beta.elsevier.com/products/elsevier-fingerprint-engine